Archives of Pharmacal Research

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Cytotoxicity of a Novel Biphenolic Compound, Bis(2-hydroxy-3-tert-butyl-5-methylphenyl)methane against Human Tumor Cells In vitro

  • Choi, Sang-Un (Pharmaceutical Screening Team, Korea Research Institute of Chemical Technology) ;
  • Kim, Kwang-Hee (Pharmaceutical Screening Team, Korea Research Institute of Chemical Technology) ;
  • Kim, Nam-Young (Pharmaceutical Screening Team, Korea Research Institute of Chemical Technology) ;
  • Choi, Eun-Jung (Pharmaceutical Screening Team, Korea Research Institute of Chemical Technology) ;
  • Lee, Chong-Ock (Pharmaceutical Screening Team, Korea Research Institute of Chemical Technology) ;
  • Son, Kwang-Hee (Bioproducts Research Group, Korea Research Institute of Bioscience and Technology, KIST) ;
  • Kim, Sung-Uk (Bioproducts Research Group, Korea Research Institute of Bioscience and Technology, KIST) ;
  • Bok, Song-Hae (Bioproducts Research Group, Korea Research Institute of Bioscience and Technology, KIST) ;
  • Kim, Young-Kook (Bioproducts Research Group, Korea Research Institute of Bioscience and Technology, KIST)
  • Published : 1996.08.01
Download PDF
⟨ Previous Next ⟩

Abstract

Phenolic compounds are prevalent as toxins or environmental pollutants, but they are also widely used as drugs for various purpose including anticancer agent. A novel biphenolic compound, bis(2-hydroxy-3-tert-butyl-5-methylphenyl)methane (GERI-BPO02-A) was isolated from the fermentation broth of Aspergillus fumigatus F93 previously, and it has revealed cytotoxicity against human solid tumor cells. Its effective doses that cause 50% inhibition of cell growth in vitro against non-small cell lung cancer cell A549, ovarian cancer cell SK-OV-3, skin cancer cell SK-MEL-2 and central nerve system cancer cell XF498 were 8.24, 10.60, 8.83, $9.85\mug/ml$ respectively. GERI-BPO02-A has also revealed cytotoxicity against P-glycoproteinexpressed human colon cancer cell HCT15 and its multidrug-resistant subline HCT15/CL02, and its cytotoxicity was not affected by P-glycoprotein. We have also tested cytotoxicities of structurally related compounds of GERI-BPO02-A such as diphenylmethane, 1,1-bis(3,4dimethylphenyl)ethane, 2,2-diphenylpropane, 2-benzylpyridine, 3-benzylpyridine, $4,4^I-di-tert-butylphenyl$, bibenzyl, $2,2^I-dimethylbibenzyl$, cis-stilbene, trans-stilbene, 3-tert-butyl-4-hydroxy-5-methylphenyisulfide, sulfadiazine and sulfisomidine for studying of structure and activity relationship, and from these data we could suppose that hydroxyl group of GERI-BPO02A conducted important role in its cytotoxicity.

Keywords

References

  1. Am. J. Physiol. v.267 Expression and function of P-glycoprotein in human mesangial cells Bello-Reuss,E.;Ernest,S.
  2. Eur. J. Cancer Clin. Oncol. v.24 Preclinical phase II studies in human tumor lines: a european multicenter study Boven,E.;Winograd,B.;Fodstad,O.;Lobbezoo,M.W.;Pinedo,H.M.
  3. Cancer Chemother. Biol. Response Modif. v.12 New anticancer agents Brown,T.D.;Burris,H.A.;Havlin,K.A.;O'Rourke,T.J.;Rodriguez,G.I.;Wall,J.G.;Weiss,G.R.
  4. Arch. Pharm. Res. v.19 Cytotoxicity of trichothecenes to human solid tumor cells in vitro Choi,S.U.;Choi,E.J.;Kim,K.H.;Kim,N.Y.;Kwon,B.M.;Kim,S.U.;Bok,S.H.;Lee,J.O.
  5. Cancer Chemother. Pharmacol. v.1 New natural products of interest under development at the National Cancer Institute Douros,J.;Suffness,M.
  6. Annu. Rev. Biochem. v.58 The biochemistry of P-glycoprotein-mediated multidrug resistance Endicott,J.A.;Ling,V.
  7. Proc. Natl. Acad. Sci. v.84 Expression of a multidrug-resistance gene in human tumors and tissues Fojo,A.T.;Ueda,K.;Slaman,D.J.;Poplack,D.G.;Gottesman,M.M.;Pastan,I.
  8. Jpn. J. Cancer Res. v.84 Multidrug resistance in rat colon carcinoma cell lines CC531, CC531$^{mdr+}$ and CC531$^{rev}$ Gheuens,E.;van der Heyden,S.;Elst,H.;Eggermont,A.;Oosterom,A.V.;De Bruijn E.
  9. J. Natl. Cancer Inst. v.81 Expression of a multidrug resistance gene in brain cancer Goldstein,L.J.;Galski,H.;Fojo,A.;Willingham,M.;Lai,S.L.;Gazdar,A.;Cossman,J.;Gottesman,M.M.;Pastan,I.
  10. J. Neurooncol. v.14 P-glycoprotein expression in brain tumors Henson,J.W.;Cordon-Cardo,C.;Posner,J.B.
  11. Anticancer Res. v.11 Establishment of multidrug resistant human coloredtal carcinoma HCT15 cell lines and their properties Iwahashi,T.;Okochi,E.;Ono,K.;Sugawara,I.;Tsuruo,T.;Mori,S.
  12. Science v.221 Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines Kartner,N.;Riordan,J.R.;Ling,V.
  13. J. Antibiotics GERI-BP002-A, novel inhibitor of acyl-CoA:cholesterol acyltransferase produced by Aspergillus fumigatus F93 Kim,Y.K.;Lee,H.W.;Son,K.H.;Kwon,B.M.;Jeong,T.S.;Lee,D.H.;Shin,J.;Seo,Y.;Kim,S.U.;Bok,S.H.
  14. Int. J. Cancer. v.49 P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma Lai,G.M.;Chen,Y.N.;Mickley,L.A.;Fojo,A.T.;Bate,S.E.
  15. Int. J. Cancer. v.49 Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines Lai,G.M.;Moscow,J.A.;Alvarez,M.G.;Fojo,A.T.;Bates,S.E.
  16. Arch. Pharm. Res. v.18 Hydrolysable tannins and related compound having cytotoxic activity From the fruits of Terminalia chebula Lee,S.H.;Ryu,S.Y.;Choi,S.U.;Lee,C.O.;No,Z.:Kim,S.K.;Ahn,J.W.
  17. Cancer Res. v.54 Reactive oxygen-dependent DNA damage resulting from the oxidation of phenolic compounds by a copper-redox cycle mechanism Li,Y.;Trush,M.A.
  18. J. Biol. Chem. v.264 Modulation of the expression of a multidrug resistance gene (mdr-1/Pglycoprotein) by differentiting agents Mickley,L.A.;Bates,S.E.;Richert,N.D.;Currier,S.;Tanaka,S.;Foss,F.;Rosen,N.;Fojo,A.T.
  19. Biochem. Pharmacol. v.45 Cytotoxic effects of biphenyl and hydroxybiphenyls on isolated rat hepatocytes Nakagawa,Y.;Tayama,S.;Moore,G.;Moldeus,P.
  20. Adv. Free Radical Biol. Med. v.2 Quinones in biology: functions in electron transfer and oxygen activation Nohl,H.;Jordan,W.;Youngman,R.J.
  21. Chem. Biol. Interact. v.80 Molecular mechanisms of quinone cytotoxicity O'Brien,P.J.
  22. J. Natl. Cancer Inst. v.86 MDR1 gene expression: Its effects on drug resistance to doxorubicin in human hepatocellular carcinoma cell lines Park,J.G.;Lee,S.K.;Hong,I.G.;Kim,H.S.;Lim,K.H.;Choe,K.J.;Kim,W.H.;Kim,Y.I.;Tsuruo,T.;Gottesman,M.M.
  23. Arch. Pharm. Res. v.17 Antitumor activity of some phenolic components in plant Ryu,S.Y.;Choi,S.U.;Lee,C.O.;Lee,S.H.;Ahn,J.W.;Zee,O.P.
  24. Arch. Pharm. Res. v.15 Anticancer activity of Psoralea corylifolia Ryu,S.Y.;Choi,S.U.;Lee,C.O.;Zee,O.P.
  25. J. Natl. Cancer Inst. v.82 New colorimetric cytotoxicity assay for anticancer-drug screening Skehan,P.;Streng,R.;SCudiero,D.;Monks,A.;McMahon,J.;Vistica,D.;Warren,J.T.;Bokesch,H.;Kenney,S.;Boyd,M.R.
  26. Recent Result Cancer Res. v.63 New anticancer antibiotics under development and clinical evaluation in the National Cancer Institute Slavik,M.
  27. Mut. Res. v.259 The beneficial and harzardous effects of simple phenolic compounds Stich,H.F.
  28. J. Natl. Cancer Inst. v.52 Cultural and antigenic properties of newly established cell strains derived from adenocarcinomas of the human colon and rectum Tompkins,W.A.F.;Watrach,A.M.;Schmale,J.D.;Schultz,R.M.;Harris,J.A.
  29. J. Biol. Chem. v.264 The peroxidase-dependent activation of butylated hydroxyanisole and butylated hydroxytoluene (BHT) to reactive intermediates Thompson,D.C.;Cha,Y.N.;Trush,M.A.
  30. Cancer Chemother Biol. Response Modif. v.10 New anticancer agents Weiss,G.R.;Arteaga,G.L.;Brown,T.D.;Craig,J.B.;Harman,G.S.;Havlin,K..A.;Koeller,J.M.;Kuhn,J.G.;Von Hoff,D.D.